Aptamer Group (STU:P0J) Total Liabilities: €1.69 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aptamer Group Total Liabilities?

Aptamer Group STU:P0J Total Liabilities is €1.69 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Aptamer Group's Total Liabilities for the quarter that ended in Dec. 2025 was €1.69 Mil.

Aptamer Group's quarterly Total Liabilities declined from Dec. 2024 (€2.15 Mil) to Jun. 2025 (€1.71 Mil) and declined from Jun. 2025 (€1.71 Mil) to Dec. 2025 (€1.69 Mil).

Aptamer Group's annual Total Liabilities declined from Jun. 2023 (€2.85 Mil) to Jun. 2024 (€2.22 Mil) and declined from Jun. 2024 (€2.22 Mil) to Jun. 2025 (€1.71 Mil).

Aptamer Group Total Liabilities Historical Data

* Premium members only.

The historical data trend for Aptamer Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aptamer Group Total Liabilities Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23 Jun24 Jun25
Total Liabilities
Get a 7-Day Free Trial 1.28 4.04 2.85 2.22 1.71

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.30 2.22 2.15 1.71 1.69

Aptamer Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Aptamer Group's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.382+(0.285+0.041
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.71

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=3.334-1.626
=1.71

Aptamer Group's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.563+(0.087+0.04
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.69

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=4.265-2.576
=1.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €1.69 Mil mean?
Aptamer Group (STU:P0J) has a Total Liabilities of €1.69 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Aptamer Group and its competitors.
Is Aptamer Group's Total Liabilities too high?
Aptamer Group's current Total Liabilities is €1.69 Mil.
How does Aptamer Group's Total Liabilities compare to VRTX and REGN?
Aptamer Group's Total Liabilities of €1.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Aptamer Group and its competitors. Aptamer Group's current Total Liabilities is €1.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptamer Group stock overvalued right now?
Aptamer Group (STU:P0J) has a current Total Liabilities of €1.69 Mil. The current Total Liabilities is €1.69 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Aptamer Group (STU:P0J), the current Total Liabilities is €1.69 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aptamer Group Business Description

Other Exchanges APTA:UKP0J:Germany
Address Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses, Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and others.